跳至主要内容
临床试验/NCT02618018
NCT02618018Unknown不适用

An Investigator-Initiated Trials on the Efficacy and Stability of AT TORBI 709M 4-haptic Toric IOL in Cataract Surgery

Seoul National University Hospital2 个研究点 分布在 2 个国家目标入组 20 人开始时间: 2015年9月最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
20
试验地点
2
主要终点
Visual acuity, refractive results

研究概览

简要总结

The purpose of this study is to evaluate the efficacy and stability of AT TORBI 709M 4-haptic toric IOL in cataract surgery.

详细描述

Inclusion criteria

  1. senile cataract
  2. patients' age of 21 years or older
  3. preoperative regular corneal astigmatism between 1.00 D and 6.00 D

Exclusion criteria

  1. pregnant, lactating women
  2. presence of other ocular diseases which affect stability of lens capsule

Primary outcome : efficacy index (visual acuity, refractive results Secondary outcome : rotational stability, endothelial cell count, cornea thickness

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • senile cataract
  • patients' age of 21 years or older
  • preoperative regular corneal astigmatism between 1.00 D and 6.00 D

排除标准

  • pregnant, lactating women
  • presence of other ocular diseases which affect stability of lens capsule

研究组 & 干预措施

intraocular lens

Experimental

AT TORBI 709M toric intraocular lens

干预措施: AT TORBI 709M (Procedure)

结局指标

主要结局

Visual acuity, refractive results

时间窗: 3 months

uncorrected distance visual acuity (UCDVA) and best corrected distance visual acuity (BCDVA) measured using logarithm of the minimum angle of resolution (logMAR) refractive results measured by keratometry

次要结局

  • Cornea thickness(3 months)
  • Rotational stability(3 months)
  • Endothelial cell count(3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验